Cytovation AS
Industry
- Pharmaceuticals
- Biotechnology
See more in Biomedtracker
Latest on Cytovation AS
Scrip
• By Mandy Jackson and Ayisha Sharma
To say that 2022 has gotten off to a rough start for investors that back biopharmaceutical companies would be an understatement. The Nasdaq Biotechnology Index (NBI) is down 14.3% year-to-date and the
Scrip
• By John Davis
The emerging Norwegian biotech company Cytovation AS has identified a potent therapeutically-active peptide, CyPep-H1, which has potential in the treatment of cutaneous warts and cancer and should
Scrip
• By Deanna Kamienski, Beth Allan, Maureen Riordan, and Steven Muntner
Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar